• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Device Problem Biocompatibility (2886)
Patient Problems Erythema (1840); Rash (2033)
Event Date 09/02/2021
Event Type  Injury  
Event Description
A journal article was submitted presenting case reports of patients treated with venaseal.Clinical case 3 presents a patient with untreated long-term bilateral varicose veins who presented with pain of the left leg with severe interference to quality of life.The patient started medical treatment with nsaids, venotropic and topical corticosteroids associated with the use of elastic stockings with initial symptomatic improvement.Symptoms then recurred associated with the appearance of an ulcer on the leg at 30 days.The doppler ultrasonography showed bilateral insufficiency of the great saphenous vein with a diameter greater than 8 mm.It was proposed to perform, in an outpatient basis treatment, with venaseal of the left great saphenous vein associated with varicose veins foam sclerotherapy dus guided which was uneventful.In the second day an erythematous rash appeared on the face prompting systemic corticosteroid therapy.After a 2-month follow-up, the patient is asymptomatic with a healed ulcer, with the imaging control showing occlusion of the great saphenous trunk.
 
Manufacturer Narrative
Title: venaseal: a good solution in the treatment of severe superficial venous insufficiency in very elderly patients author: marta machado, miguel machado, arlindo matos journal: angiologia e cirurgia vascular year: 2021 vol/issue: 17(3) ref: 10.48750/acv.409.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14050650
MDR Text Key288851768
Report Number9612164-2022-01369
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age97 YR
Patient SexFemale
-
-